APIs are the backbone of the pharmaceutical industry, embodying the bridge between scientific discovery and therapeutic application. As we move towards a future of more personalized and targeted therapies, the role of APIs will inevitably expand, driven by innovation and a commitment to patient safety. Understanding APIs and their impact on drug products is crucial for stakeholders across the healthcare spectrum, from manufacturers to regulatory agencies, and ultimately, the patients who rely on these life-saving medications.
In recent years, the quest for youthfulness and longevity has spurred an increasing interest in various supplements and nutraceuticals. One compound that has emerged as a promising candidate in this arena is β-nicotinamide mononucleotide (NMN). As a derivative of niacin, NMN plays a crucial role in cellular metabolism and energy production, raising eyebrows and hopes in both the scientific community and the general public.
Calcium is vital for bone health, as it is a major component of bone tissue. It helps maintain bone density and strength. Adults require about 1,000 to 1,200 mg of calcium daily, with higher amounts recommended for those healing from fractures. Foods rich in calcium include dairy products, leafy greens, and fortified foods.